The Latest Breaking News from FDA

As ever, be cautious about what you hear from the Department of Health and Human Services.

Bored Panda contacted four dermatologists and plastic surgeons to find out more about Kybella, the FDA-approved treatment that targets the stubborn "double chin."

The U.S. government is nearing a partial shutdown, with a range of effects on public services and the broader economy

Penny stocks are highly volatile, but some of them have the potential to deliver outsized returns.

Guess which conservative think tank supplied the "evidence" for this one...

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are at high risk of complications, including the elderly and/or those with congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) or…

RFK Jr is conducting a review of mifepristone, citing a deeply flawed study. The move could be devastating for women

US class action lawsuit alleges company failed to warn about risks of using contraceptive injection Depo-Provera

AI is reshaping healthcare by improving outcomes and easing burnout. See how three companies are leading this transformation

A great menu can’t save a place that treats guests poorly. Service sets the tone, protects margins, and builds repeat visits. When it’s bad, costs rise, reviews crash, and regulars vanish. You notice it fast: long waits, missing items, mixed-up bills. If you care about your time and money, spotting…

The impact of Robert F Kennedy Jr on US health organisations will affect research funding and access to medicines but may force Australia to step up, say experts